LSE Health, London School of Economics and Political Science, Houghton Street, London, WC2A 2AE, UK,
Appl Health Econ Health Policy. 2013 Dec;11(6):639-52. doi: 10.1007/s40258-013-0056-7.
Universal access to health care in most western European countries has been a given for many decades; however, macroeconomic developments and increased pressure on health care budgets could mean the status quo cannot be maintained. As populations age, a declining proportion of economically active citizens are being required to support a larger burden of health and social care, while increasing availability of novel technologies for extending and improving life continues to push health care costs upwards. With health expenditure continuing to rise as a proportion of national income, concerns are raised about the current and future financial sustainability of Organisation for Economic Co-Operation and Development (OECD) health care systems. Against this backdrop, a discussion about options to fund health care in the future, including whether to raise additional health care finance (and the ways to do so), reallocate resources and/or ration services becomes very pertinent.
This study elicits preferences among a group of key stakeholders (payers, providers, government, academia and health-related industry) on the issue of health care financial sustainability and the future funding of health care services, with a view to understanding the different degrees of acceptability between policy interventions and future funding options as well as their feasibility.
We invited 842 individuals from academia, other research organisations (eg. think tanks), national health services, providers, health insurance organisations, government representatives and health-related industry and related advisory stakeholders to participate in an online survey collecting preferences on a variety of revenue-generating mechanisms and cost/demand reducing policies. Respondents represented the 28 EU member states as well as Norway, Iceland, Switzerland, Australia, Russian Federation, Canada and New Zealand.
We received 494 responses to our survey from all stakeholder groups. Across all groups, the highest preference was for policies to modify lifestyle and implement more extensive screening within risk groups for high burden illnesses. There was a broad consensus not to reallocate resources from social security/education. Between stakeholders, there were differences of opinion between industry/advisory and a range of other groups, with industry being generally more in favour of market-based interventions and an increased role for the private sector in health care financing/delivery. Conversely, stakeholders from academia, government, national health services and insurance were relatively more in favour of more restrictive purchasing of new and expensive technologies, and (to varying extent) of higher income/corporate taxes. Taxes on cigarettes/alcohol were by far considered the most politically feasible option.
According to this study, policy options that are broadly acceptable across stakeholder groups with different inherent interests exist but are limited to lifestyle modification, screening interventions and excise taxes on harmful products. Representatives from the private sector tend to view solutions rooted in the private sector as both effective and politically feasible options, while stakeholders from academia and the public sector seem to place more emphasis on solutions that do not disproportionately impact certain population groups.
在大多数西欧国家,全民享有医疗保健服务已经有几十年了;然而,宏观经济的发展和医疗保健预算的压力增加,可能意味着现状无法维持。随着人口老龄化,经济活跃公民的比例下降,需要支持更大的健康和社会护理负担,而新型技术的可用性不断增加,以延长和改善生命,这继续推高医疗保健成本。随着医疗支出在国民收入中所占比例的持续上升,人们对经合组织(OECD)医疗保健系统的当前和未来财务可持续性表示担忧。在这种背景下,人们开始讨论未来为医疗保健提供资金的选择,包括是否增加额外的医疗保健资金(以及筹集资金的方式)、重新分配资源和/或对服务进行配给。
本研究旨在了解不同政策干预措施和未来供资选择之间的可接受程度以及可行性,从而了解一组主要利益相关者(支付者、提供者、政府、学术界和与健康相关的行业)对医疗保健财务可持续性和未来医疗保健服务供资问题的看法。
我们邀请了来自学术界、其他研究组织(如智库)、国家卫生服务机构、提供者、健康保险组织、政府代表以及与健康相关的行业和相关咨询利益相关者的 842 名个人参加在线调查,以收集对各种创收机制和降低成本/需求政策的偏好。受访者代表了 28 个欧盟成员国以及挪威、冰岛、瑞士、澳大利亚、俄罗斯联邦、加拿大和新西兰。
我们从所有利益相关者群体收到了 494 份对我们调查的回复。在所有群体中,最高的偏好是针对高负担疾病风险群体实施生活方式改变和更广泛筛查的政策。各方普遍认为不应从社会保障/教育中重新分配资源。在利益相关者之间,行业/咨询和一系列其他群体之间存在意见分歧,行业普遍更倾向于基于市场的干预措施和私营部门在医疗保健融资/提供方面发挥更大作用。相反,来自学术界、政府、国家卫生服务机构和保险公司的利益相关者则相对更倾向于对新的和昂贵的技术进行更严格的采购,并且(在不同程度上)对更高的收入/公司税持赞成态度。到目前为止,对香烟/酒精征税被认为是最具政治可行性的选择。
根据这项研究,存在广泛为不同利益相关群体所接受的政策选择,但仅限于生活方式改变、筛查干预和对有害产品征收消费税。来自私营部门的代表认为植根于私营部门的解决方案是有效和具有政治可行性的选择,而来自学术界和公共部门的利益相关者似乎更强调不会不成比例地影响某些人群的解决方案。